JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 30 May 2008

Journal of Endocrinology 2008;198:271.

Journal of Endocrinology (2008) In press  DOI: 10.1677/JOE-08-0063

Final version of this article was published in Journal of Endocrinology 2008, Vol 198, Iss 2, 271-279
© 2008 Society for Endocrinology

This Article
Right arrow Accepted manuscript (PDF)
Right arrow Supplementary figures
Right arrow All Versions of this Article:
JOE-08-0063v1
198/2/271    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Artner, I.
Right arrow Articles by Stein, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Artner, I.
Right arrow Articles by Stein, R.

RESEARCH

MaFA is a dedicated activator of the insulin gene in vivo

Isabella Artner, Yan Hang, Min Guo, Guoqiang Gu and Roland Stein

I Artner, Stem Cell Center, Lund University, Lund, 22184, Sweden
Y Hang, Nashville, United States
M Guo, Molecular Physiology and Physiology, Vanderbilt University Medical Center, Nashville, United States
G Gu, Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, United States
R Stein, Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, United States

Correspondence: Isabella Artner, Email: isabella.artner{at}med.lu.se

Abstract

As successful generation of insulin producing cells could be used for diabetes treatment, a concerted effort is being made to understand the molecular programs underlying islet beta cell formation and function. The closely related MafA and MafB transcription factors are both key mammalian beta cell regulators. MafA and MafB are co-expressed in insulin+ beta cells during embryogenesis, while in the adult pancreas MafA is only produced in beta cells and MafB in glucagon+ alpha cells. MafB-/- animals are also deficient in insulin+ and glucagon+ cell production during embryogenesis. However, only MafA over-expression selectively induced endogenous Insulin mRNA production in cell line based assays, while MafB specifically promoted Glucagon expression. Here we analyzed if these factors were sufficient to induce insulin+ and/or glucagon+ cell formation within embryonic endoderm using the chick in ovo electroporation assay. Ectopic expression of MafA, but not MafB, promoted Insulin production, however neither MafA nor MafB were capable of inducing Glucagon. Co-electroporation of MafA with the Ngn3 transcription factor resulted in the development of more organized cell clusters containing both insulin and glucagon producing cells. Analysis of chimeric proteins of MafA and MafB demonstrated that chick Insulin activation depended on sequences within the MafA C-terminal DNA binding domain. MafA was also bound to Insulin and Glucagon transcriptional control sequences in mouse embryonic pancreas and beta cell lines. Collectively, these results demonstrate a unique ability for MafA to independently activate Insulin transcription.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Endocrinology.